Insiders · PRQR

PRQR insider transactions

ProQR Therapeutics N.V. (PRQR) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

PRQR insiders

Everyone who has filed a Form 4 or 5 at ProQR Therapeutics N.V., latest first. Follow anyone to get their next filing.

• Daniel Anton de BoerChief Executive Officer, Director+$853K
• Bart FiliusDirector+$489K
• Gylvin Lykke HinschDirector

Recent Form 3, 4, and 5 filings for PRQR

• 94d
  Chief Executive Officer De Boer Daniel Anton bought $353,960 worth of Ordinary Shares (200,000 units at $1.77), increasing direct ownership by 67% to 500,000 units (SEC Form 4)

  4 - ProQR Therapeutics N.V. (0001612940) (Issuer)
• 108d
  Director Filius Bart bought $257,925 worth of Ordinary Shares (150,000 units at $1.72), increasing direct ownership by 100% to 300,000 units (SEC Form 4)

  4 - ProQR Therapeutics N.V. (0001612940) (Issuer)
• 116d
  Chief Executive Officer De Boer Daniel Anton bought $261,000 worth of Ordinary Shares (150,000 units at $1.74), increasing direct ownership by 100% to 300,000 units (SEC Form 4)

  4 - ProQR Therapeutics N.V. (0001612940) (Issuer)
• 120d
  Chief Executive Officer De Boer Daniel Anton bought $238,500 worth of Ordinary Shares (150,000 units at $1.59) (SEC Form 4)

  4 - ProQR Therapeutics N.V. (0001612940) (Issuer)
• 128d
  Amendment: SEC Form 4 filed by Director Hinsch Gylvin Lykke

  4/A - ProQR Therapeutics N.V. (0001612940) (Issuer)
• 128d
  Director Filius Bart bought $231,000 worth of Ordinary Shares (150,000 units at $1.54) (SEC Form 4)

  4 - ProQR Therapeutics N.V. (0001612940) (Issuer)
• 155d
  SEC Form 4 filed by Director Hinsch Gylvin Lykke

  4 - ProQR Therapeutics N.V. (0001612940) (Issuer)
• 156d
  SEC Form 3 filed by new insider Hinsch Gylvin Lykke

  3 - ProQR Therapeutics N.V. (0001612940) (Issuer)
• 232d
  SEC Form 3 filed by new insider Valerio Domenico

  3 - ProQR Therapeutics N.V. (0001612940) (Issuer)
• 232d
  SEC Form 3 filed by new insider Platenburg Gerardus Johannes

  3 - ProQR Therapeutics N.V. (0001612940) (Issuer)
• 232d
  SEC Form 3 filed by new insider Maier Martin Alexander

  3 - ProQR Therapeutics N.V. (0001612940) (Issuer)
• 232d
  SEC Form 3 filed by new insider Lawton Alison Frances

  3 - ProQR Therapeutics N.V. (0001612940) (Issuer)
• 232d
  SEC Form 3 filed by new insider Hom Dennis

  3 - ProQR Therapeutics N.V. (0001612940) (Issuer)
• 232d
  SEC Form 3 filed by new insider Heggie Theresa

  3 - ProQR Therapeutics N.V. (0001612940) (Issuer)
• 232d
  SEC Form 3 filed by new insider Filius Bart

  3 - ProQR Therapeutics N.V. (0001612940) (Issuer)
• 232d
  SEC Form 3 filed by new insider De Boer Daniel Anton

  3 - ProQR Therapeutics N.V. (0001612940) (Issuer)
• 232d
  SEC Form 3 filed by new insider Carreno-Gomez Begona

  3 - ProQR Therapeutics N.V. (0001612940) (Issuer)
• 232d
  SEC Form 3 filed by new insider Shannon James Samuel

  3 - ProQR Therapeutics N.V. (0001612940) (Issuer)